Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
Enrico M Messalli, Cono ScaffaDepartment of Gynaecology, Obstetrics and Reproductive Medicine, Second University of Naples, Largo Madonna delle Grazie 1, Naples, ItalyAbstract: The integrity of bone tissue and its remodeling that occurs throughout life requires a coordinated activity of osteoblasts...
Saved in:
Main Authors: | Enrico M Messalli (Author), Cono Scaffa (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006) -
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
by: Michael Pazianas, et al.
Published: (2010) -
Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis
by: Inderjeeth CA, et al.
Published: (2014) -
Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients
by: Salari M., et al.
Published: (2023) -
Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
by: Toda A, et al.
Published: (2017)